Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.60 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 1/20 | 0.55 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.54 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.53 |
| ▸ | GPR34 | Q9UPC5 | 3/20 | 0.53 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4422103 | 0.86 | MEN1 (0.66) | KMT2AMAOBNR4A2MEN1GAA | |
| SCHEMBL31710781 | 0.83 | KMT2A (0.59) | KMT2AHTTMEN1GAAKDM4E | |
| SCHEMBL379281 | 0.81 | MAOB (0.67) | MRGPRX4MAOBNR4A2NR1H4FFAR4 | |
| SCHEMBL2137838 | 0.79 | MRGPRX4 (0.69) | MRGPRX4MAOBNR4A2HDAC4 | |
| SCHEMBL2858346 | 0.79 | PKM (0.63) | KMT2AHTTMEN1GAA | |
| SCHEMBL10272935 | 0.79 | SMN1; SMN2 (0.62) | KMT2AHTTMEN1GAAKDM4E | |
| SCHEMBL1171850 | 0.78 | MRGPRX4 (0.65) | MRGPRX4MAOBNR4A2NR1H4SMPD1 | |
| SCHEMBL12746034 | 0.78 | NR4A2 (0.58) | MRGPRX4MAOBNR4A2NR1H4HDAC4 | |
| SCHEMBL16180318 | 0.78 | ALDH1A1 (0.53) | KMT2AHTTMAOBMEN1GAA | |
| Hydrochloric Acid SCHEMBL10955756 | 0.77 | PKM (0.61) | KMT2AHTTMEN1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250325542-A1 | INHIBITORS OF ANTIMOCROBIAL RESISTANCE AND METHOS USING SAME | BAYLOR COLLEGE MEDICINE (US) | 2025-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325542-A1 | INHIBITORS OF ANTIMOCROBIAL RESISTANCE AND METHOS USING SAME | BPGM, PNMT, DDT | KMT2A 381/4885HTT 2650/4885MRGPRX4 4175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.